Top

Published in:

01-07-2016 | Original Article

The efficacy of zymosan in pro-inflammatory cytokine production by peritoneal macrophages of melanoma-bearing mice

Authors: Mehdi Taghavi, Esmaeil Mortaz, Alireza Khosravi, Donya Nikaein, Abbas Barin, Ghasem Vahedi, Hojjatollah Shokri

Published in: Comparative Clinical Pathology | Issue 4/2016

Abstract

Zymosan, a polysaccharide derived from yeast cell wall, has been widely applied as a macrophage-activating factor. Application of immunomodulatory compounds as cancer therapeutics has emerged in recent years. The goal of this study was to assess the effect of zymosan in the modulation of pro-inflammatory cytokines in melanoma-bearing mice. C57BL/6 mice were divided into four groups of seven mice including zymosan (Z group), melanoma (M group), zymosan treated melanoma-bearing mice (ZM group), and control (C group). Mice were treated with zymosan (10 μg) for four continuous days. At the end of the last day (25 days after tumor induction), blood samples and peritoneal macrophages were collected and mice were euthanized. The levels of IL-1β and IL-6 were measured in sera by enzyme-linked immunosorbent assay (ELISA). The expression of messenger RNA (mRNA) levels was analyzed by real-time polymerase chain reaction (RT-PCR). The results showed that zymosan significantly increases both serum release and mRNA levels of IL-1β and IL-6 in mice-bearing melanoma. Phagocytic activity of macrophages increased significantly by zymosan. Thus, our data may suggest that zymosan has a potential activity in cancer regulation and might be used as an adjuvant role in conventional cancer treatment.

Adams S, O’Neill DW, Nonaka D, Hardin E, Chiriboga L, Siu K, Cruz CM, Angiulli A, Angiulli F, Ritter E (2008) Immunization of malignant melanoma patients with full-length NY-ESO-1 protein using TLR7 agonist imiquimod as vaccine adjuvant. J Immunol 181:776–784CrossRefPubMedPubMedCentral

Akira S, Takeda K (2004) Toll-like receptor signalling. Nat Rev Immunol 4:499–511CrossRefPubMed

Albeituni SH, Yan J (2013) The effects of β-glucans on dendritic cells and implications for cancer therapy. Anti Cancer Agents Med Chem 13:689–698CrossRef

Baldridge JR, McGowan P, Evans JT, Cluff C, Mossman S, Johnson D, Persing D (2004) Taking a toll on human disease: toll-like receptor 4 agonists as vaccine adjuvants and monotherapeutic agents. Expert Opin Biol Ther 4:1129–1138CrossRefPubMed

Basith S, Manavalan B, Yoo TH, Kim SG, Choi S (2012) Roles of toll-like receptors in cancer: a double-edged sword for defense and offense. Arch Pharm Res 35:1297–1316CrossRefPubMed

Brown GD, Herre J, Williams DL, Willment JA, Marshall AS, Gordon S (2003) Dectin-1 mediates the biological effects of β-glucans. J Exp Med 197:1119–1124CrossRefPubMedPubMedCentral

Dent G, Giembycz MA, Rabe KF, Barnes PJ (1991) Inhibition of eosinophil cyclic nucleotide PDE activity and opsonised zymosan-stimulated respiratory burst by ‘type IV’ selective PDE inhibitors. Br J Pharmacol 103:1339–1346CrossRefPubMedPubMedCentral

Dillon S, Agrawal S, Banerjee K, Letterio J, Denning TL, Oswald-Richter K, Kasprowicz DJ, Kellar K, Pare J, van Dyke T (2006) Yeast zymosan, a stimulus for TLR2 and dectin-1, induces regulatory antigen-presenting cells and immunological tolerance. J Clin Investig 116:916–928CrossRefPubMedPubMedCentral

Gil-de-Gómez L, Astudillo AM, Guijas C, Magrioti V, Kokotos G, Balboa MA, Balsinde J (2014) Cytosolic group IVA and calcium-independent group VIA phospholipase A2s act on distinct phospholipid pools in zymosan-stimulated mouse peritoneal macrophages. J Immunol 192:752–762CrossRefPubMed

Godson C, Mitchell S, Harvey K, Petasis NA, Hogg N, Brady HR (2000) Cutting edge: lipoxins rapidly stimulate nonphlogistic phagocytosis of apoptotic neutrophils by monocyte-derived macrophages. J Immunol 164:1663–1667CrossRefPubMed

Goodridge HS, Simmons RM, Underhill DM (2007) Dectin-1 stimulation by Candida albicans yeast or zymosan triggers NFAT activation in macrophages and dendritic cells. J Immunol 178:3107–3115CrossRefPubMed

Gryglewski RJ, Szczeklik A, Wandzilak M (1987) The effect of six prostaglandins, prostacyclin and iloprost on generation of superoxide anions by human polymorphonuclear leukocytes stimulated by zymosan or formyl-methionyl-leucyl-phenylalanine. Biochem Pharmacol 36:4209–4213CrossRefPubMed

Hsiao Y-W, Liao K-W, Hung S-W, Chu R-M (2004) Tumor-infiltrating lymphocyte secretion of IL-6 antagonizes tumor-derived TGF-β1 and restores the lymphokine-activated killing activity. J Immunol 172:1508–1514CrossRefPubMed

Humes J, Sadowski S, Galavage M, Goldenberg M, Subers E, Bonney R, Kuehl F (1982) Evidence for two sources of arachidonic acid for oxidative metabolism by mouse peritoneal macrophages. J Biol Chem 257:1591–1594PubMed

Hussein MR (2005) Ultraviolet radiation and skin cancer: molecular mechanisms. J Cutan Pathol 32:191–205CrossRefPubMed

Jayaraman P, Sada-Ovalle I, Nishimura T, Anderson AC, Kuchroo VK, Remold HG, Behar SM (2013) IL-1β promotes antimicrobial immunity in macrophages by regulating TNFR signaling and caspase-3 activation. J Immunol 190:4196–4204CrossRefPubMedPubMedCentral

Kaczanowska S, Joseph AM, Davila E (2013) TLR agonists: our best frenemy in cancer immunotherapy. J Leukoc Biol 93:847–863CrossRefPubMedPubMedCentral

Kagari T, Doi H, Shimozato T (2002) The importance of IL-1β and TNF-α, and the noninvolvement of IL-6, in the development of monoclonal antibody-induced arthritis. J Immunol 169:1459–66CrossRefPubMed

Kirkwood JM, Tarhini AA, Panelli MC, Moschos SJ, Zarour HM, Butterfield LH, Gogas HJ (2008) Next generation of immunotherapy for melanoma. J Clin Oncol 26:3445–3455CrossRefPubMed

Lamkanfi M, Malireddi RS, Kanneganti T-D (2009) Fungal zymosan and mannan activate the cryopyrin inflammasome. J Biol Chem 284:20574–20581CrossRefPubMedPubMedCentral

Lu H (2014) TLR agonists for cancer immunotherapy: tipping the balance between the immune stimulatory and inhibitory effects. Front Immunol. doi:10.3389/fimmu.2014.00083

Mosser DM, Edwards JP (2008) Exploring the full spectrum of macrophage activation. Nat Rev Immunol 8:958–969CrossRefPubMedPubMedCentral

Novak M, Vetvicka V (2008) β-glucans, history, and the present: immunomodulatory aspects and mechanisms of action. J Immunotoxicol 5:47–57CrossRefPubMed

Overwijk WW, Restifo NP (2001) B16 as a mouse model for human melanoma. Curr Protoc Immunol. doi:10.1002/0471142735.im2001s39 PubMedPubMedCentral

Perkhofer S, Speth C, Dierich MP, Lass-Flörl C (2007) In vitro determination of phagocytosis and intracellular killing of Aspergillus species by mononuclear phagocytes. Mycopathologia 163:303–307CrossRefPubMed

Pillemer L, Schoenberg MD, Blum L, Wurz L (1955) Properdin system and immunity: II. Interaction of the properdin system with polysaccharides. Science 122:545–549CrossRefPubMed

Restifo NP, Dudley ME, Rosenberg SA (2012) Adoptive immunotherapy for cancer: harnessing the T cell response. Nat Rev Immunol 12:269–281CrossRefPubMed

Sahoo BR, Basu M, Swain B, Dikhit MR, Jayasankar P, Samanta M (2013) Elucidation of novel structural scaffold in rohu TLR2 and its binding site analysis with peptidoglycan, lipoteichoic acid and zymosan ligands, and downstream MyD88 adaptor protein. BioMed Res Int. doi:10.1155/2013/185282

Sato A, Ohtaki H, Tsumuraya T, Song D, Ohara K, Asano M, Iwakura Y, Atsumi T, Shioda S (2012) Interleukin-1 participates in the classical and alternative activation of microglia/macrophages after spinal cord injury. J Neuroinflammation. doi:10.1186/1742-2094-9-65

Scheel O, Papavlassopoulos M, Blunck R, Gebert A, Hartung T, Zähringer U, Seydel U, Schromm AB (2006) Cell activation by ligands of the toll-like receptor and interleukin-1 receptor family depends on the function of the large-conductance potassium channel MaxiK in human macrophages. Infect Immun 74:4354–4356CrossRefPubMedPubMedCentral

Scheller J, Chalaris A, Schmidt-Arras D, Rose-John S (2011) The pro-and anti-inflammatory properties of the cytokine interleukin-6. Biochimica et Biophysica Acta (BBA)-Molecular. Cell Res 1813:878–888

Slack EC, Robinson MJ, Hernanz‐Falcón P, Brown GD, Williams DL, Schweighoffer E, Tybulewicz VL, Reis e Sousa C (2007) Syk-dependent ERK activation regulates IL-2 and IL-10 production by DC stimulated with zymosan. Eur J Immunol 37:1600–1612CrossRefPubMed

Song JS, Kim Y-J, Han KU, Yoon BD, Kim JW (2015) Zymosan and PMA activate the immune responses of Mutz3-derived dendritic cells synergistically. Immunol Lett 167:41–46CrossRefPubMed

Stewart BW, Kleihues P (2003) World cancer report. IARC press, Lyon

Talmadge JE, Singh RK, Fidler IJ, Raz A (2007) Murine models to evaluate novel and conventional therapeutic strategies for cancer. Am J Pathol 170:793–804CrossRefPubMedPubMedCentral

Tang Q, Adams JY, Penaranda C, Melli K, Piaggio E, Sgouroudis E (2008) Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction. Immunity 28:687–97CrossRefPubMedPubMedCentral

Underhill DM (2003) Macrophage recognition of zymosan particles. J Endotoxin Res 9:176–180CrossRefPubMed

Veronesi U, Adamus J, Aubert C, Bajetta E, Beretta G, Bonadonna G, Bufalino R, Cascinelli N, Cocconi G, Durand J (1982) A randomized trial of adjuvant chemotherapy and immunotherapy in cutaneous melanoma. N Engl J Med 307:913–916CrossRefPubMed

Waldmann TA (2006) Effective cancer therapy through immunomodulation. Annu Rev Med 57:65–81CrossRefPubMed

Wang Q, Cao X, Wang J, Zhang W, Tao Q, Ye T (2000) Macrophage activation of lymphoma-bearing mice by liposome-mediated intraperitoneal IL-2 and IL-6 gene therapy. Chin Med J 113:281–285PubMed

Xia Y, Ross GD (1999) Generation of recombinant fragments of CD11b expressing the functional β-glucan-binding lectin site of CR3 (CD11b/CD18). J Immunol 162:7285–7293PubMed

Title: The efficacy of zymosan in pro-inflammatory cytokine production by peritoneal macrophages of melanoma-bearing mice
Authors: Mehdi Taghavi
Esmaeil Mortaz
Alireza Khosravi
Donya Nikaein
Abbas Barin
Ghasem Vahedi
Hojjatollah Shokri
Publication date: 01-07-2016
Publisher: Springer London
Published in: Comparative Clinical Pathology / Issue 4/2016
Print ISSN: 1618-5641
Electronic ISSN: 1618-565X
DOI: https://doi.org/10.1007/s00580-016-2269-2

At a glance: The STEP trials

Springer Medicine

The efficacy of zymosan in pro-inflammatory cytokine production by peritoneal macrophages of melanoma-bearing mice

Abstract

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2016

Myiasis caused by Cephalopina titillator (Diptera: Oestridae) in camels (Camelus dromedarius) of semi-arid areas in Iran: distribution and associated risk factors

The effect of Iresine herbstii Hook on some haematological parameters of experimentally induced anaemic rats

Blood biochemistry responses of ducks infected with a velogenic Newcastle disease virus

Porcine circovirus type 2 expression in the brain of neonatal piglets with congenital tremor

Diagnostic efficacy of abattoir meat inspection for detecting bovine tuberculosis at Adama municipal abattoir, Ethiopia

Ethanol effects on histobiochemical parameters of suckling pups borned from alcoholic rat mothers